Dr. Gil Ronen, CEO and co-founder of the Israel-based NRGene, talks to Marc Zienkiewicz about why the genomics AI company is choosing Saskatchewan for its Canadian head office as announced last week.
Ronen was involved extensively in plant genomics at Compugen and the AgBio discovery company Evogene. His last senior positions at Evogene were as chief scientist and vice-president of intellectual property. Ronen holds a PhD in plant genetics from the Hebrew University of Jerusalem.
